Literature DB >> 9751039

First shots fired in biological warfare.

M Wheelis.   

Abstract

Mesh:

Year:  1998        PMID: 9751039     DOI: 10.1038/26089

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  36 in total

1.  Use of a recombinant burkholderia intracellular motility a protein for immunodiagnosis of glanders.

Authors:  Subodh Kumar; Praveen Malik; Shailendra Kumar Verma; Vijai Pal; Vandana Gautam; Chiranjay Mukhopadhyay; Ganga Prasad Rai
Journal:  Clin Vaccine Immunol       Date:  2011-07-13

2.  Burkholderia mallei CLH001 Attenuated Vaccine Strain Is Immunogenic and Protects against Acute Respiratory Glanders.

Authors:  Christopher L Hatcher; Tiffany M Mott; Laura A Muruato; Elena Sbrana; Alfredo G Torres
Journal:  Infect Immun       Date:  2016-07-21       Impact factor: 3.441

3.  A proposal for the classification of biological weapons sensu lato.

Authors:  Lajos Rozsa
Journal:  Theory Biosci       Date:  2014-07-04       Impact factor: 1.919

4.  Antibodies against In Vivo-Expressed Antigens Are Sufficient To Protect against Lethal Aerosol Infection with Burkholderia mallei and Burkholderia pseudomallei.

Authors:  Shawn M Zimmerman; Jeremy S Dyke; Tomislav P Jelesijevic; Frank Michel; Eric R Lafontaine; Robert J Hogan
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

5.  Evaluation of PCR, DNA hybridization and immunomagnetic separation - PCR for detection of Burkholderia mallei in artificially inoculated environmental samples.

Authors:  S Merwyn; S Kumar; G S Agarwal; G P Rai
Journal:  Indian J Microbiol       Date:  2010-03-05       Impact factor: 2.461

6.  Use of Immunohistochemistry to Demonstrate In Vivo Expression of the Burkholderia mallei Virulence Factor BpaB During Experimental Glanders.

Authors:  Shawn M Zimmerman; Mackenzie E Long; Jeremy S Dyke; Tomislav P Jelesijevic; Frank Michel; Eric R Lafontaine; Robert J Hogan
Journal:  Vet Pathol       Date:  2017-11-16       Impact factor: 2.221

7.  The type IV pilin of Burkholderia mallei is highly immunogenic but fails to protect against lethal aerosol challenge in a murine model.

Authors:  Paula J Fernandes; Qin Guo; David M Waag; Michael S Donnenberg
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

8.  Protection from pneumonic infection with burkholderia species by inhalational immunotherapy.

Authors:  Andrew Goodyear; Lisa Kellihan; Helle Bielefeldt-Ohmann; Ryan Troyer; Katie Propst; Steven Dow
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

9.  Distinct human antibody response to the biological warfare agent Burkholderia mallei.

Authors:  John J Varga; Adam Vigil; David DeShazer; David M Waag; Philip Felgner; Joanna B Goldberg
Journal:  Virulence       Date:  2012-10-01       Impact factor: 5.882

10.  Comparison of the in vitro and in vivo susceptibilities of Burkholderia mallei to Ceftazidime and Levofloxacin.

Authors:  Barbara M Judy; Gregory C Whitlock; Alfredo G Torres; D Mark Estes
Journal:  BMC Microbiol       Date:  2009-05-09       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.